Overview

A Study Of PF-05175157 In Healthy Volunteers

Status:
Completed

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single oral doses of PF-05175157 in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer